Noonberg Sarah B. 4
4 · Metagenomi, Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Noonberg Sarah B.
Chief Medical Officer
Transactions
- Award
Common Stock
2024-04-01+57,763→ 100,374 total - Award
Stock Option (Right to Buy)
2024-04-01+242,875→ 242,875 totalExercise: $10.82Exp: 2034-03-31→ Common Stock (242,875 underlying)
Footnotes (2)
- [F1]These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2025, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
- [F2]25% of the shares subject to this option shall vest and become exercisable on April 1, 2025, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.